BCL2 and breast cancer: Interestingly, luteolin triggered apoptosis through the downregulation of the human telomerase reverse transcriptase (hTERT) via the NF-κB/c-Myc pathway, which correlated to increased Bax/Bcl-2 ratio and caspase-3 protein expression in human breast cancer cells [32].